BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

797 related articles for article (PubMed ID: 18044697)

  • 1. A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease.
    Zadikoff C; Fox SH; Tang-Wai DF; Thomsen T; de Bie RM; Wadia P; Miyasaki J; Duff-Canning S; Lang AE; Marras C
    Mov Disord; 2008 Jan; 23(2):297-9. PubMed ID: 18044697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's disease.
    Videnovic A; Bernard B; Fan W; Jaglin J; Leurgans S; Shannon KM
    Mov Disord; 2010 Feb; 25(3):401-4. PubMed ID: 20108371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes on brief cognitive instruments over time in Parkinson's disease.
    Lessig S; Nie D; Xu R; Corey-Bloom J
    Mov Disord; 2012 Aug; 27(9):1125-8. PubMed ID: 22692724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild cognitive impairment in symptomatic and asymptomatic cerebrovascular disease.
    Popović IM; Serić V; Demarin V
    J Neurol Sci; 2007 Jun; 257(1-2):185-93. PubMed ID: 17328916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment.
    Lee JY; Dong Woo Lee ; Cho SJ; Na DL; Hong Jin Jeon ; Kim SK; You Ra Lee ; Youn JH; Kwon M; Lee JH; Maeng Je Cho
    J Geriatr Psychiatry Neurol; 2008 Jun; 21(2):104-10. PubMed ID: 18474719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Montreal Cognitive Assessment: a screening tool for mild cognitive impairment in REM sleep behavior disorder.
    Gagnon JF; Postuma RB; Joncas S; Desjardins C; Latreille V
    Mov Disord; 2010 May; 25(7):936-40. PubMed ID: 20310038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of two brief screening measures of cognitive impairment in Huntington's disease.
    Mickes L; Jacobson M; Peavy G; Wixted JT; Lessig S; Goldstein JL; Corey-Bloom J
    Mov Disord; 2010 Oct; 25(13):2229-33. PubMed ID: 20721924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of subtle cognitive impairment in stroke-free patients with carotid disease.
    Martinić-Popović I; Lovrencić-Huzjan A; Demarin V
    Acta Clin Croat; 2009 Sep; 48(3):231-40. PubMed ID: 20055242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.
    Kulisevsky J; Pagonabarraga J
    Mov Disord; 2009 Jun; 24(8):1103-10. PubMed ID: 19353727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Montreal Cognitive Assessment (MoCA) is superior to the Mini-Mental State Examination (MMSE) for the detection of vascular cognitive impairment after acute stroke.
    Dong Y; Sharma VK; Chan BP; Venketasubramanian N; Teoh HL; Seet RC; Tanicala S; Chan YH; Chen C
    J Neurol Sci; 2010 Dec; 299(1-2):15-8. PubMed ID: 20889166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the montreal cognitive assessment superior to the mini-mental state examination in detecting subtle cognitive impairment among middle-aged outpatient U.S. Military veterans?
    Whitney KA; Mossbarger B; Herman SM; Ibarra SL
    Arch Clin Neuropsychol; 2012 Nov; 27(7):742-8. PubMed ID: 22763350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive decline in early Parkinson's disease.
    Kandiah N; Narasimhalu K; Lau PN; Seah SH; Au WL; Tan LC
    Mov Disord; 2009 Mar; 24(4):605-8. PubMed ID: 19191342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment.
    Fujiwara Y; Suzuki H; Yasunaga M; Sugiyama M; Ijuin M; Sakuma N; Inagaki H; Iwasa H; Ura C; Yatomi N; Ishii K; Tokumaru AM; Homma A; Nasreddine Z; Shinkai S
    Geriatr Gerontol Int; 2010 Jul; 10(3):225-32. PubMed ID: 20141536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the short test of mental status and the mini-mental state examination in mild cognitive impairment.
    Tang-Wai DF; Knopman DS; Geda YE; Edland SD; Smith GE; Ivnik RJ; Tangalos EG; Boeve BF; Petersen RC
    Arch Neurol; 2003 Dec; 60(12):1777-81. PubMed ID: 14676056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Montreal Cognitive Assessment and the mini-mental state examination as screening instruments for cognitive impairment: item analyses and threshold scores.
    Damian AM; Jacobson SA; Hentz JG; Belden CM; Shill HA; Sabbagh MN; Caviness JN; Adler CH
    Dement Geriatr Cogn Disord; 2011; 31(2):126-31. PubMed ID: 21282950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MoCA: well-suited screen for cognitive impairment in Parkinson disease.
    Dalrymple-Alford JC; MacAskill MR; Nakas CT; Livingston L; Graham C; Crucian GP; Melzer TR; Kirwan J; Keenan R; Wells S; Porter RJ; Watts R; Anderson TJ
    Neurology; 2010 Nov; 75(19):1717-25. PubMed ID: 21060094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive decline correlates with neuropathological stage in Parkinson's disease.
    Braak H; Rüb U; Del Tredici K
    J Neurol Sci; 2006 Oct; 248(1-2):255-8. PubMed ID: 16814807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mini-Mental State Examination versus Montreal Cognitive Assessment: rapid assessment tools for cognitive and functional outcome after aneurysmal subarachnoid hemorrhage.
    Schweizer TA; Al-Khindi T; Macdonald RL
    J Neurol Sci; 2012 May; 316(1-2):137-40. PubMed ID: 22280947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining mild cognitive impairment in Parkinson's disease.
    Caviness JN; Driver-Dunckley E; Connor DJ; Sabbagh MN; Hentz JG; Noble B; Evidente VG; Shill HA; Adler CH
    Mov Disord; 2007 Jul; 22(9):1272-7. PubMed ID: 17415797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.